The Pharmacy Times® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.
July 18th 2025
GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.
FDA Proposes the Removal and Addition of Substances to Its 503A Bulks List
January 2nd 2017The FDA has created a new proposed rule that adds 6 bulk drug substances to an existing list of substances that can be used in compounding. It has also proposed the removal of 4 other bulk drug substances from the list.
Read More
Parenteral Nutrition Compounding Practices at Work
December 8th 2016Health-system pharmacies can regulate cost-effective and efficient operations for parenteral nutrition compounding practices. Laura Mark, MS, PharmD, FASHP, led a tech talk at the Baxter Booth at the ASHP Midyear Clinical Meeting to discuss parenteral nutrition compounding practices.
Read More